Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America”

3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,063
Index total 30,257
Page 35 / 128

Quick answer

This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,063 results for “The United States of America” · 30,257 patents in full index Clear search

  1. US 10076535

    Use of CPG oligonucleotides co-formulated with an antibiotic to accelerate wound healing

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 18, 2018 · Expires Sep 13, 2038

    granted

  2. US 10072078

    M971 chimeric antigen receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted

  3. US 10072084

    Dual specific immunotoxin for brain tumor therapy

    The United States of America as Represented by the Secretary Department of Health and Human Services (NIH) · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted

  4. US 10072070

    Potent anti-influenza A neuraminidase subtype N1 antibody

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted

  5. US 10071945

    Nuclear receptor modulators and their use for the treatment and prevention of cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 11, 2018 · Expires Sep 6, 2038

    granted

  6. US 10064858

    Methods and compositions for treating bacterial infections with iron chelators

    The United States of America as represented by the Secretary of the Army · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted

  7. US 10064933

    Recombinant rift valley fever (RVF) viruses and methods of use

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Sep 4, 2018 · Expires Aug 30, 2038

    granted

  8. US 10058559

    Treatment or prevention of an intestinal disease or disorder

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted

  9. US 10058602

    Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 28, 2018 · Expires Aug 23, 2038

    granted

  10. US 10052374

    Compositions, methods and uses for dengue virus serotype-4 constructs

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 21, 2018 · Expires Aug 16, 2038

    granted

  11. US 10052369

    Aquaporin 2 protects cattle from ticks and tick-borne parasites

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 21, 2018 · Expires Aug 16, 2038

    granted

  12. US 10051880

    Hydroxybutyrate ester and medical use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 21, 2018 · Expires Aug 16, 2038

    granted

  13. US 10053503

    Monoclonal antibodies that neutralize anthrax toxins

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 21, 2018 · Expires Aug 16, 2038

    granted

  14. US 10053514

    Human bispecific EGFRvIII and CD3 antibody engaging molecules

    The United States of America as Represented by the Secretary of Health and Human Services, National Institutes of Health · Granted Aug 21, 2018 · Expires Aug 16, 2038

    granted

  15. US 10052382

    Methods for using antibodies for 3′ iso-LM1 and 3′, 6′-iso-LD1tumor gangliosides

    The United States of America as Represented by the Secretary of Health (NIH) · Granted Aug 21, 2018 · Expires Aug 16, 2038

    granted

  16. US 10046024

    Cyclic-GluR6 analogs, methods of treatment and use

    The United States of America, as represented by National Institutes of Health (NIH), U.S. Dept of Health and Human Services (DHHS), NIH Division of Extramural Inventions and Technology Resource (DEITR) · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted

  17. US 10047148

    Neutralizing GP41 antibodies and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted

  18. US 10046012

    Multipotent postnatal stem cells from human periodontal ligament and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted

  19. US 10047401

    Expression protein-coding and noncoding genes as prognostic classifiers in early stage lung cancer

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted

  20. US 10047147

    Neutralizing GP41 antibodies and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted

  21. US 10047122

    Peptide and peptide mimetic binding antagonists of polo-like kinase 1 polo box domain and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Aug 14, 2018 · Expires Aug 9, 2038

    granted

  22. US 10039818

    Attenuated pasteurella multocida strains

    The United States of America, as represented by the Secretary of Agriculture · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted

  23. US 10040826

    Human immunodeficiency virus type 1 (HIV-1) N-terminal deleted GP120 immunogens

    The United States of America as represented by the Secretary of the Army · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted

  24. US 10040830

    Methods and compositions for protein delivery

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Aug 7, 2018 · Expires Aug 2, 2038

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.